Viromed Medical AG (HAM:VMED) Cash And Cash Equivalents : €0.02 Mil (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Viromed Medical AG Cash And Cash Equivalents?

Viromed Medical AG's quarterly cash and cash equivalents increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€0.20 Mil) but then stayed the same from Dec. 2023 (€0.20 Mil) to Jun. 2024 (€0.02 Mil).

Viromed Medical AG's annual cash and cash equivalents declined from Dec. 2021 (€0.25 Mil) to Dec. 2022 (€0.15 Mil) but then increased from Dec. 2022 (€0.15 Mil) to Dec. 2023 (€0.20 Mil).

Viromed Medical AG Cash And Cash Equivalents Historical Data

The historical data trend for Viromed Medical AG's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Viromed Medical AG Cash And Cash Equivalents Chart

Viromed Medical AG Annual Data

Trend

Dec21

Dec22

Dec23

Cash And Cash Equivalents

0.25

0.15

0.20

Viromed Medical AG Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Cash And Cash Equivalents	Get a 7-Day Free Trial			0.23	0.15	-	0.20	0.02

Viromed Medical AG Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Viromed Medical AG (HAM:VMED) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Viromed Medical AG Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Viromed Medical AG's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Viromed Medical AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Viromed Medical AG (HAM:VMED) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

VMED:Germany

Address

Flensburger Str. 18, Pinneberg, SH, DEU, 25421

Website

https://www.viromed-medical-ag.de

Viromed Medical AG is engaged in developing medical devices. The company offers wound healing technology solutions.

Executives

Uwe Perbandt	Board of Directors
Katrin Kunstmann	Supervisory Board
Pd Dr. Markus Perbandt	Supervisory Board

Viromed Medical AG Headlines

No Headlines